510(k) K160571
K160571 is an FDA 510(k) premarket notification submitted by Roche Diagnostics Operations (Rdo) for the device "cobas c513 Analyzer, cobas c13 Tina-quant HbA1cDx Gen.3 Assay". The FDA issued a decision of Substantially Equivalent on Dec 19, 2016. The device falls under product code PDJ (Hemoglobin A1c Test System), a Class II device regulated under 21 CFR 862.1373. Roche Diagnostics Operations (Rdo) has 13 other 510(k) clearances on record.
Clearance details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- Dec 19, 2016
- Date Received
- Feb 29, 2016
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device classification
- Device Name
- Hemoglobin A1c Test System
- Device Class
- Class II
- Regulation Number
- 862.1373
- Review Panel
- CH
- Submission Type
- 510(k)
Quantitative determination of Hemoglobin A1c to aid in the diagnosis of diabetes.
Need the full FDA record for Roche Diagnostics Operations (Rdo)? Ask Claude or ChatGPT with the RegDataLab connector and get every site's inspections, Form 483s, warning letters, recalls and import alerts, each with a link to the FDA source. The API key is free: no card.